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A B S T R A C T 19 
 20 
The lysosomal cysteine protease activity of Trypanosoma brucei comprises a cathepsin B 21 
enzyme (TbCATB) and a cathepsin L enzyme (TbCATL). Inhibition of the cysteine protease 22 
activity is lethal to bloodstream-form trypanosomes but it was not entirely clear which of the 23 
two enzymes are essential for survival of the parasites. Here we show that the vinyl sulfone 24 
compound LU-102 selectively inhibits TbCATL without affecting TbCATB and the 25 
proteasomal trypsin-like activity within trypanosomes. Therefore, the trypanocidal activity 26 
displayed by LU-102 can be attributed solely to the inhibition of TbCATL demonstrating that 27 
this enzyme is essential to the survival of T. brucei. 28 
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Bloodstream forms of Trypanosoma brucei express two cathepsin-like cysteine proteases, 36 
cathepsin B (TbCATB) and cathepsin L (TbCATL) [1,2]. With respect to the three subspecies 37 
of T. brucei, T. b. brucei, T. b. rhodesiense and T. b. gambiense, the enzymes show high 38 
sequence identity to each other (TbCATL: >98%; TbCATB: >99%). The two enzymes are 39 
localised to the lysosomal compartment and are involved in the degradation of endocytosed 40 
host proteins [3,4]. TbCATL is responsible for the majority of the cysteine protease activity 41 
[5]. Both proteases have been implicated to be essential for the survival of the parasite [3,4]. 42 
RNA interference data indicated the essentiality of TbCATB despite only a modest reduction 43 
of 32% of the TbCATB protein [4] while chemical target validation studies using small-44 
molecule cysteine proteases inhibitors pointed towards TbCATL as the vital enzyme [6]. Using 45 
the newly developed compound LU-102 (Fig. 1), we show here that inhibition of TbCATL 46 
alone is sufficient to kill bloodstream forms of T. brucei in vitro. 47 
The compound LU-102 is a peptidyl vinyl sulfone and was initially developed as an 48 
inhibitor of the trypsin-like activity of the mammalian proteasome [7]. By contrast, LU-102 49 
was recently shown not to inhibit the trypsin-like activity of the proteasome of T. brucei [8]. 50 
The observed trypanocidal activity of LU-102 was subsequently attributed to the activity of the 51 
compound to inhibit also cathepsins [7,8]. Other targets could be excluded because peptidyl 52 
vinyl sulfones react exclusively with active site cysteine sulfhydryl and threonine hydroxyl; 53 
they do not react with the serine hydroxyl of serine proteases [9]. 54 
First, the inhibitory selectivity of LU-102 for TbCATB and TbCATL was determined using 55 
T. brucei cell extracts with the fluorogenic substrates Z-RR-AMC (benzyloxycarbonyl-arginyl-56 
arginyl-7-amido-4-methyl coumarin) and Z-FR-AMC (benzyloxycarbonyl-phenylalanyl-57 
arginyl-7-amido-4-methyl coumarin). Whereas Z-RR-AMC is cleaved by TbCATB but not by 58 
TbCATL, both TbCATB and TbCATL hydrolyse Z-FR-AMC [10,11]. LU-102 showed a dose-59 
dependent inhibitory effect on the Z-FR-AMC hydrolysing activity with a half-maximal 60 
inhibitory concentration (IC50) of 0.39 µM (Fig. 2A). As hydrolysis of Z-FR-AMC is mainly 61 
due to the activity of TbCATL, this finding indicates that LU-102 is an inhibitor of cathepsin 62 
L. On the other hand, the Z-RR-AMC hydrolysing activity was unaffected by LU-102 (Fig. 63 
2A). As Z-RR-AMC is only cleaved by TbCATB, this result suggests that LU-102 does not 64 
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inhibit this enzyme. The remaining Z-FR-AMC hydrolysing activity observed at 100 µM LU-65 
102 (14.4% of control) was probably due to uninhibited TbCATB activity and/or to TbCATL 66 
that was not completely inhibited. 67 
Next, the trypanocidal activity of LU-102 was determined with bloodstream forms of T. 68 
brucei using the resazurin (Alamar blue) assay described previously [12]. LU-102 showed a 69 
dose-dependent effect on the growth of trypanosomes with a MIC (minimum inhibitory 70 
concentration, i.e., that concentration of a compound at which all cells were killed) value of 25 71 
µM and a GI50 (50% growth inhibition, i.e., that concentration of a compound necessary to 72 
reduce the growth rate of cells by 50% to that of controls) value 10.2 μM (Fig 2B). Whereas a 73 
MIC value was not determined previously, the GI50 value was comparable to that recently 74 
published (6.9 µM [8]). Based on the findings that LU-102 does not inhibit TbCATB (see 75 
above) and the trypsin-like activity of the trypanosomal proteasome [8], the trypanocidal 76 
activity of the compound seems to be solely due to inhibition of TbCATL, indicating that 77 
blocking the activity of TbCATL is sufficient to kill bloodstream forms of T. brucei. 78 
In order to prove that the trypanocidal activity of LU-102 is indeed only due to inhibition 79 
of TbCATL, bloodstream forms of T. brucei were incubated with the compound for 2 h at the 80 
lethal concentration of 25 µM (MIC value; see Fig. 2B) and the residual peptidase activity in 81 
cell extracts was measured using Z-FR-AMC and Z-RR-AMC. The Z-FR-AMC hydrolysing 82 
activity was inhibited by 95.0% after incubating trypanosomes for 2 h with 25 µM LU-102 83 
(Fig. 3A). The remaining hydrolytic activity of 5.0% was most likely due to TbCATB as the 84 
Z-FR-AMC hydrolysing activity was almost completely abolished (by 99.6%) in parasites 85 
incubated with 25 µM of the non-selective cysteine protease inhibitor Z-Phe-Ala-86 
diazomethylketone (Z-FA-DMK) for 2 h (Fig. 3B). On the other hand, the Z-RR-AMC 87 
hydrolysing activity was only inhibited by 27.0% after exposing the parasites for 2 h to 25 µM 88 
LU-102 (Fig. 3A). However, Z-RR-AMC hydrolysing activity in trypanosomes treated with 89 
LU-102 was not statistically significantly different from that of control parasites (Fig. 3A). In 90 
contrast, treatment of trypanosomes with 25 µM Z-FA-DMK for 2 h resulted in 94.6% 91 
inhibition of the Z-RR-AMC hydrolysing activity (Fig. 3B). These findings confirm the 92 
suggestion that LU-102 is not a potent inhibitor of TbCATB. In addition, an inhibition of 93 
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TbCATB by 27.0% would certainly not be sufficient to kill bloodstream forms of T. brucei. 94 
For example, the CATB-specific inhibitor CA-074 was shown to inhibit TbCATB in 95 
trypanosomes by 95% after incubating the parasites with 100 µM of the compound for 2 h, yet 96 
CA-074 displayed no trypanocidal activity [6]. 97 
There was a slight difference in the inhibitory potency of LU-102 when using cell extract 98 
and live trypanosomes. Whereas 100 µM LU-102 inhibited the Z-FR-AMC hydrolysing 99 
activity by 85.6% in cell extract, 25 µM of the compound caused 95.0% inhibition of this 100 
peptidolytic activity in live trypanosomes (compare Fig 2A with Fig. 3A). Likewise, 100 µM 101 
LU-102 blocked the Z-RR-AMC hydrolysing activity by only 4.2% in cell extract, whereas 25 102 
µM of the compound inhibited this peptidolytic activity by 27.0% in live trypanosomes 103 
(compare Fig 2A with Fig. 3B). However, it has been shown that many cysteine protease 104 
inhibitors suppress more efficiently TbCATL and TbCATB activity within trypanosomes than 105 
in trypanosome cell lysates [6]. The reason for this is that the intralysosomal milieu is a 106 
reducing environment [13-15] which facilitates the inactivation reaction of cysteine protease 107 
inhibitors with the active site cysteine residue. This suggestion was confirmed by 108 
demonstrating that cathepsin enzymes are more efficiently inhibited by cysteine protease 109 
inhibitors in the presence of thiols (dithiothreitol (DTT) and glutathione) [5,6]. To determine 110 
whether a reducing environment enhances the inhibitory potency of LU-102, the effect of the 111 
reducing agent DTT on the inhibition of the Z-FR-AMC and Z-RR-AMC hydrolysing activity 112 
by LU-102 in cell extracts was investigated. In the absence of DTT, pre-incubation of cell 113 
extracts with 25 μM of LU-102 inhibited the hydrolysis of Z-FR-AMC by 69.9% (Fig 3C). In 114 
contrast, in the presence of 2.5 mM DTT, pre-treatment of cell extracts with 25 µM LU-102 115 
lead to 94.8% inhibition (Fig. 3C), which was almost identical to the extent of inhibition 116 
observed in live trypanosomes (95.0%; see Fig. 3A). Likewise, pre-treatment of cell extract 117 
with the compound in the absence of DTT resulted in the inhibition of the Z-RR-AMC 118 
hydrolytic activity by just 7.4% while in the presence of the thiol the hydrolysis of the peptide 119 
was inhibited by 21.7% (Fig. 3D). The inhibition in presence of DTT was similar to that 120 
observed for LU-102 in live trypanosomes (27.0%; see Fig. 3B). However, as for live 121 
trypanosomes, the inhibition of the Z-RR-AMC hydrolysing activity by LU-102 in cell extracts 122 
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in the presence of DTT was not statistically significantly different from that of the DMSO 123 
control (Fig. 3B). These findings confirm that the inhibition reaction of LU-102 with the active 124 
site cysteine residue of TbCATB and TbCATL is enhanced in a reducing environment. 125 
Previously it was shown that inhibition of lysosomal cysteine proteases in bloodstream-126 
form trypanosomes is associated with the accumulation of transferrin in the lysosome [16,17]. 127 
Further analysis revealed that only blockage of TbCATL resulted in considerable accumulation 128 
of transferrin in the lysosome while inhibition of TbCATB did not interfere with the 129 
degradation of the iron-transport protein [6]. To determine whether treatment of trypanosomes 130 
with LU-102 leads to accumulation of transferrin within the lysosome, parasites were incubated 131 
with fluorescein-labelled transferrin in the presence of 25 µM LU-102 or Z-FA-DMK for 2 h. 132 
Treatment of trypanosomes with 25 µM LU-102 led to the accumulation of transferrin (Fig. 133 
3E). Based on the median of the fluorescence intensity signal, LU-102 treated trypanosomes 134 
accumulated 4.7-times more transferrin than control cells treated with DMSO alone (Fig. 3E). 135 
However, trypanosomes incubated with 25 μM Z-FA-DMK accumulated about twice more 136 
transferrin than LU-102 treated cells (Fig. 3E). This result showed that inhibition of TbCATL 137 
by LU-102 also led to substantial accumulation of transferrin, a prerequisite for any CATL 138 
inhibitor in order to be trypanocidal. 139 
Although we have recently shown that LU-102 at 10 µM did not significantly inhibit the 140 
trypsin-like activity of the trypanosomal proteasome in cell extracts [8], there might be the 141 
possibility that at the higher concentration of 25 µM the compound inhibits the proteasomal 142 
trypsin-like activity more readily facilitated by the intracellular reducing environment. To 143 
exclude this possibility, bloodstream forms of T. brucei were incubated with 25 µM LU-102 144 
for 2 h and the proteasomal trypsin-like activity in cell extracts was subsequently measured 145 
using the fluorogenic trypsin-like peptide substrate Boc-LSTR-AMC. Under the experimental 146 
conditions, LU-102 inhibited the trypsin-like activity by 13.5% (Fig. 3F). However, the trypsin-147 
like activity in trypanosomes treated with LU-102 was not statistically significantly different 148 
from that of control parasites (Fig. 3F). The observed extent of inhibition of the trypsin-like 149 
activity by LU-102 within trypanosomes is in line with that recently reported in trypanosome 150 
cell extracts (13.5% inhibition at 25 µM within cells compared to 8.7% inhibition at 10 µM in 151 
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cell lysate) [8]. The finding shows that LU-102 also does not substantially inhibit the trypsin-152 
like activity within trypanosomes. In addition, the observed limited inhibition of the 153 
proteasomal trypsin-like activity is certainly not sufficient to explain the trypanocidal activity 154 
of LU-102. 155 
A previous chemical validation study using a variety of cysteine protease inhibitors 156 
provided evidence suggesting that TbCATL rather than TbCATB is essential to the survival of 157 
T. brucei bloodstream forms [6]. This conclusion was reached based on the observation that 158 
the CATB-specific inhibitor CA-074 displayed no trypanocidal activity although the 159 
compound inhibited almost completely the activity of TbCATB within trypanosomes [6]. As 160 
all other inhibitors employed suppressed considerably the activity of both TbCATL and 161 
TbCATB, it remained unclear whether not both proteases needed to be inhibited in order to kill 162 
the parasite. In this study, we have now shown that inhibition of TbCATL alone is sufficient to 163 
kill bloodstream forms of T. brucei. This was only possible as the vinyl sulfone compound LU-164 
102 selectively inhibited the activity of TbCATL in trypanosomes without affecting TbCATB 165 
and the trypsin-like activity of the trypanosomal proteasome. The finding that TbCATL is 166 
essential to the survival of bloodstream forms of T. brucei suggests that future drug 167 
development programmes should focus on the rational design of TbCATL inhibitors. 168 
 169 
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Figure legends 224 
 225 
Fig. 1. Chemical structure of LU-102. The PubChem Compound Identifier (CID) of LU-102 226 
is 71562351. 227 
 228 
Fig. 2. (A) Effect of LU-102 on cysteine protease activity in cell extracts of T. brucei. 229 
Bloodstream forms of T. brucei 427-221a were harvested, washed once with PBS/1% glucose 230 
and lysed in 100 mM citrate, pH 5.0, 2% CHAPS on ice for 10 min. After centrifugation at 231 
16873g for 5 min, aliquots of clarified cell extracts were treated with different concentrations 232 
of LU-102 (10-fold serial dilutions from 100 µM to 1 nM) in the presence of 10% DMSO for 233 
30 min at room temperature. Controls were treated with 10% DMSO alone. Then, 16 µl of 234 
samples containing 1  106 and 1  107 cell equivalents for determining TbCATB/L and 235 
TbCATB activity, respectively, were added to 1984 µl measuring buffer (100 mM citrate, pH 236 
5.0, 2 mM DTT) containing 5 µM Z-FR-AMC and Z-RR-AMC, respectively. After 30 min 237 
(TbCATB/L) or 120 min (TbCATB), the fluorescence of released AMC was measured at 238 
excitation and emission wavelengths of 360 nm and 460 nm in a BIORAD VersaFluor 239 
fluorometer. Open circles, TbCATB/L activity; open squares, TbCATB activity. Data are mean 240 
values ± SD of three experiments. (B) Trypanocidal activity of LU-102. Bloodstream forms of 241 
T. brucei 427-221a were seeded in 96-well plates in a final volume of 200 μl Baltz medium 242 
containing 2-fold serial dilutions of LU-102 (100 µM to 0.78125 µM) and 1% DMSO. Control 243 
cultures contained medium and 1% DMSO. The initial cell density was 1  104 244 
trypanosomes/ml. After 24 h incubation at 37 °C in a humidified atmosphere containing 5% 245 
CO2, 20 μl of a 0.5 mM resazurin solution prepared in sterile PBS was added and the cells were 246 
incubated for a further 48 h so that the total incubation time was 72 h. Thereafter, the plates 247 
were read on a microplate reader using a test wavelength of 570 nm and a reference wavelength 248 
of 630 nm. Data are mean values ± SD of three experiments. 249 
 250 
Fig. 3. (A,B) Effect of LU-102 on Z-FR-AMC and Z-RR-AMC the hydrolysis activity within 251 
trypanosomes. Bloodstream forms of T. brucei 427-221a (2  107/ml) were incubated with 25 252 
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μM of LU-102 or 25 µM Z-FA-DMK in Baltz medium in the presence of 2.5% DMSO at 37 253 
°C in a humidified atmosphere containing 5% CO2. Control cultures were incubated in medium 254 
containing 2.5% DMSO. After 2 h incubation, cells were harvested by centrifugation and 255 
washed three times with PBS/1% glucose. Then, cell pellets (2  107/100 μl) were lysed in 100 256 
mM citrate, pH 5.0, 2% CHAPS on ice for 10 min. Subsequently, lysates were centrifuged and 257 
clarified supernatants were used to determine TbCATB/L and TbCATB activity in measuring 258 
buffer (100 mM citrate, pH 5.0, 2 mM DTT) in the presence of 5 μM Z-FR-AMC and Z-RR-259 
AMC, respectively. For TbCATB/L activity (A), 10 µl of cell lysate corresponding to 2  106 260 
cell equivalents were added to 1990 µl measuring buffer. For TbCATB activity (B), 60 µl 261 
corresponding to 1.2  107 cell equivalents were added to 1940 µl measuring buffer. After 15 262 
min (TbCATB/L) and 60 min (TbCATB) incubation at room temperature, respectively, the 263 
release of free AMC was measured at excitation and emission wavelengths of 360 and 460 nm, 264 
respectively, in a BIORAD VersaFluor fluorometer. Specific activities (pmol AMC 265 
released/min/cell) were calculated using a standard curve constructed with uncoupled AMC. 266 
Data are mean values ± SD of three experiments. (C,D) Effect of DTT on inhibition of cysteine 267 
peptidase activity in cell extracts of trypanosomes by LU-102. Cell extracts of bloodstream 268 
form T. brucei 427-221a (prepared as described in Fig. 2) were pre-treated with 25 μM LU-269 
102 or the equivalent amount of DMSO (10%) alone in the absence or presence of 2.5 mM 270 
DTT for 30 min at room temperature. Then, 16 µl of samples containing 0.35-0.40  106 and 271 
0.26-0.44  107 cell equivalents for determining TbCATB/L and TbCATB activity, 272 
respectively, were added to 1984 µl measuring buffer (see Fig. 2) containing 5 µM Z-FR-AMC 273 
and Z-RR-AMC, respectively. After 30 min (TbCATB/L, C) or 120 min (TbCATB, D), the 274 
fluorescence of released AMC was measured and specific activities calculated as described 275 
above. Data are mean values ± SD of three experiments. (E) Effect of LU-102 on the 276 
accumulation of fluorescein-labelled transferrin in trypanosomes. Bloodstream forms of T. 277 
brucei (1  107/ml) were incubated with 50 µg/ml fluorescein-labelled bovine transferrin in 278 
Baltz medium supplemented with 2% BSA in the presence of 25 µM LU-102 and 2.5% DMSO 279 
(orange line). Control cultures were treated with 2.5% DMSO alone (red line; negative control) 280 
or with 25 µM Z-FA-DMK plus 2.5% DMSO (blue line; positive control). After 2 h incubation, 281 
12 
 
cells were washed twice with PBS/1% glucose and fixed with 2% formaldehyde/0.05% 282 
glutaraldehyde in PBS. Accumulated fluorescein-labelled transferrin within trypanosomes was 283 
determined using a CyFlow Cube 6 flow cytometer. (F) Effect of LU-102 on the proteasomal 284 
trypsin-like activity within trypanosomes. Bloodstream forms of T. brucei 427-221a (2  285 
107/ml) were incubated with 25 μM of LU-102 in Baltz medium in the presence of 2.5% DMSO 286 
at 37 °C in a humidified atmosphere containing 5% CO2. Control cultures were incubated in 287 
medium containing 2.5% DMSO. After 2 h incubation, cells were harvested by centrifugation 288 
and washed three times with PBS/1% glucose. Then, cell pellets (1  107/100 μl) were lysed in 289 
10 mM Tris, 0.1 mM EDTA, pH 7.0, 0.2% NP-40, 2 mM ATP and 1 mM DTT on ice for 10 290 
min. Subsequently, lysates were centrifuged (16873g for 5 min) and clarified supernatants were 291 
used to determine the proteasomal trypsin-like activity in 50 mM HEPES, pH 7.5 with 5 µM 292 
Boc-LSTR-AMC. After 30 min, the fluorescence of released AMC was measured and specific 293 
activities calculated as described above. Data are mean values ± SD of three experiments. 294 
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Fig. 3 (continued) 314 
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